Ethics approval and consent to participate
INFECTIOUS DISEASES
The study was approved by the Ethics Committee of the Lazzaro Spallanzani National Institute for Infectious Diseases of Rome which has been attributed the role of National Ethics Committee for assessing clinical trials on medicines for human use and medical devices for patients with COVID-19 and by the Italian Drug Agency (AIFA), EudraCT Number: 2020-001308-40. Informed consent was obtained from all enrolled patients.The study was performed in accordance with relevant guidelines/regulations.Informed consent was obtained from all participants and/or their legal guardians.